+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Why Moderna's betting big on gene editing

Nov 15, 2021, 20:13 IST
Business Insider
A scientist at Moderna works on research at the biotech's R&D hub in Norwood, Massachusetts Franco Sacchi/Insider

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...

The scientist who helped Moderna became a vaccine powerhouse told us why he thinks gene editing is the future for the $91 billion biotech

Read more>>

Moderna has soared over the last year on the back of its coronavirus vaccine. Radek Mica/Getty Images
2 states offer COVID-19 booster shots to all adults, bypassing CDC guidance

Dive in>>

Advertisement

People waiting for a mass Covid-19 testing in Vienna, Austria, Friday, Dec 4, 2020. AP Photo/Ronald Zak
An Austrian province is preparing a COVID-19 lockdown for unvaccinated people only, saying the vaccinated shouldn't have to 'lose their freedom'

Get the full story>>

More stories we're reading:

-Leah

Next Article